-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Aptiv, Lowers Price Target to $61

Benzinga·10/06/2026 09:33:28
Listen to the news
Goldman Sachs analyst Mark Delaney maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $71 to $61.